Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // October 27th, 2010 // 6:46 am
Good morning, folks. Nice to see you again. We hope this is the start of another sunny day for you, despite the cloudy forecast for the greater Pharmalot metropolitan region. So please join us as we grab the mandatory cup of stimulation and prepare for those looming meetings and deadlines. Hope your day goes well and drop us a line if you hear of anything interesting…
PhRMA Says Puerto Rico’s Tax Law To Hinder Offshore Firms (Outsourcing Pharma)
Novartis Doubles Boston Expansion Plans (The Boston Globe)
Elan Reports A Third-Quarter Loss (Associated Press)
UK’s NICE Rejects Glaxo’s Revolade For Blood Condition (Dow Jones)
Canada’s Access To Meds Bill Has Grim Prognosis (Toronto Globe & Mail)
Bristol-Myers Drug May Be Delayed By Factory Problems (Associated Press)
Boehringer And Pfizer Sign Technology Deal With MacroGenics (PharmaTimes)
FDA Fast Tracks AIDS Gel (Reuters)
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
AIDS, AIDS Gel, Boehringer Ingelheim, Bristol Myers Squibb, Canada, Elan, GlaxoSmithKline, MacroGenics, NICE, Pfizer, Phrma, Puerto Rico, Revolade